We are live on ! Find out more
ARTA

A.R.T. Advisors Portfolio holdings

AUM $1.79M
1-Year Est. Return 57.47%
This Fund
S&P 500
This Quarter Est. Return
+30.54%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
AUM
$66.7M
AUM Growth
+$61M
Cap. Flow
+$56.1M
Cap. Flow %
84.13%
Top 10 Hldgs %
15.15%
Holding
292
New
261
Increased
15
Reduced
3
Closed
12

Top Buys

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$1.06M
2
MCD icon
McDonald's
MCD
+$971K
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$945K
4
DAL icon
Delta Air Lines
DAL
+$930K
5
NKE icon
Nike
NKE
+$886K

Sector Composition

Rank Sector Weight
1 Financials 15.64%
2 Consumer Discretionary 13.27%
3 Technology 13.27%
4 Real Estate 13.21%
5 Healthcare 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMAN
251
DELISTED
eMagin Corporation
EMAN
$23K 0.03%
+29,000
New +$15.3K
NBRV
252
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$22K 0.03%
+132
New +$22K
YELL
253
DELISTED
Yellow Corporation Common Stock
YELL
$22K 0.03%
+11,952
New +$19.5K
RMTI icon
254
Rockwell Medical
RMTI
$27.2M
$21K 0.03%
+99
New +$23.4K
WPRT
255
Westport Fuel Systems
WPRT
$31.9M
$21K 0.03%
+1,710
New +$19.1K
ZSAN
256
DELISTED
Zosano Pharma Corporation
ZSAN
$21K 0.03%
+717
New +$20.2K
ALTO icon
257
Alto Ingredients
ALTO
$338M
$20K 0.03%
+28,200
New +$14.2K
RIGL icon
258
Rigel Pharmaceuticals
RIGL
$723M
$20K 0.03%
+1,080
New +$19.4K
ACOR
259
DELISTED
Acorda Therapeutics
ACOR
$20K 0.03%
+230
New +$24.3K
MCHX icon
260
Marchex
MCHX
$78M
$19K 0.03%
+12,025
New +$18.2K
TLPH icon
261
Talphera
TLPH
$68M
$18K 0.03%
+741
New +$20.6K
VRDN icon
262
Viridian Therapeutics
VRDN
$2.2B
$18K 0.03%
+1,107
New +$12.6K
KA
263
DELISTED
Kineta, Inc. Common Stock
KA
$18K 0.03%
+93
New +$19K
BIOC
264
DELISTED
Biocept, Inc.
BIOC
$18K 0.03%
+83
New +$11.9K
TELL
265
DELISTED
Tellurian Inc.
TELL
$15K 0.02%
+12,926
New +$16.4K
HTGM
266
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$15K 0.02%
+116
New +$10.2K
KOPN icon
267
Kopin
KOPN
$586M
$14K 0.02%
+10,655
New +$8.92K
ONDK
268
DELISTED
On Deck Capital, Inc.
ONDK
$14K 0.02%
+19,837
New +$19.5K
MUX icon
269
McEwen Inc
MUX
$1B
$12K 0.02%
+1,190
New +$11.1K
CARM
270
DELISTED
Carisma Therapeutics
CARM
$11K 0.02%
+755
New +$10.2K
LCTX icon
271
Lineage Cell Therapeutics
LCTX
$264M
$11K 0.02%
+12,825
New +$11.3K
CLUB
272
DELISTED
Town Sports International Holdings, Inc.
CLUB
$11K 0.02%
+19,700
New +$11.4K
VVUS
273
DELISTED
Vivus Inc
VVUS
$11K 0.02%
+12,964
New +$15.4K
MTNB icon
274
Matinas BioPharma
MTNB
$1.91M
$10K 0.02%
+267
New +$10.2K
TNXP icon
275
Tonix Pharmaceuticals
TNXP
$152M
0

Similar funds

A.R.T. Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, A.R.T. Advisors held 292 positions worth $66.7M, up 1,069% from $5.71M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

A.R.T. Advisors deployed $56.1M of net new capital in Q2 2020, opening 261 new positions and adding to 15 existing holdings. Its largest new stake was Equinix: 1,560 shares worth $1.1M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 0% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Mid-America Apartment Communities, an estimated $248K trimmed.

  • A.R.T. Advisors's largest Q2 2020 buy was Equinix: 1,560 shares worth $1.1M.
  • A.R.T. Advisors added most to Alphabet (Google) Class C in Q2 2020, an estimated $945K increase.
  • A.R.T. Advisors's biggest Q2 2020 reduction was Mid-America Apartment Communities, cutting an estimated $248K.
  • A.R.T. Advisors fully exited Healthpeak Properties in Q2 2020, selling an estimated $606K.
  • A.R.T. Advisors's ten largest holdings make up 15% of its $66.7M portfolio in Q2 2020.
  • A.R.T. Advisors opened 261 new positions and closed 12 in Q2 2020.
  • A.R.T. Advisors's portfolio value rose 1,069% quarter-over-quarter to $66.7M.

Based on A.R.T. Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.